FDA Approves Ustekinumab Biosimilar Pyzchiva Posted on July 2, 2024 by gutsandgrowth 7/1/24 FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US Share this: Email a link to a friend (Opens in new window) Email Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related
